AcouPlasma

Blood plasma separation module

AcouPlasma

AcouTrap AcouWash

Automated preparation of cell and exosome samples

AcouTrap

AcouWash

A Game Changer in Automated Sample Preparation

AcouSort uses sound waves to separate blood into its components, to isolate and purify cells and extracellular vesicles and to perform rapid reactions. With our adaptable technology, automated sample preparation is tailored to address a wide range of applications – from biomarker discovery in early research to point of care diagnostics.

AcouSort offers stand-alone products for automated sample handling, custom solutions through joint development and OEM modules that are easy to integrate into almost any analytical instrument.

Automated
Time-saving
Gentle to the sample
Easy to integrate
Label free
Non-contact

Products

Benchtop Research Systems

AcouTrap

Automated handling of cells and extracellular vesicles

  • Rapid automation of staining & binding assays
  • Isolation & purification of extracellular vesicles
  • Excellent handling of low cell numbers
  • Capture viruses and bacteria
Read more

AcouWash

Automated cell and blood sample separations

  • Separation of plasma from whole blood
  • Blood cell separation (mononuclear cells, circulating tumor cells, white blood cell subpopulations)
  • Gentle cell wash
  • Separation of bacteria and platelets from blood
Read more

AcouPlasma

Enabling access to blood plasma

  • Optical or physical access to blood plasma
  • Small footprint device
  • In-line integration with sample flow-path
  • Easy integration into analytical and diagnostic systems and consumables
Read more

What’s so special about our technology?

Learn how we can enable fast and accurate diagnostics.

Dec
5
2022

Two of AcouSort’s board members and CEO acquire shares

AcouSort AB (publ) (“AcouSort” or the “Company”) today announces that founders and board members Thomas Laurell and Stefan Scheding...

Read More
Dec
1
2022

The BioWings project creates new opportunities for large-scale production and exosome-based diagnostics

AcouSort and its collaborators are now finishing the 4-year BioWings project which has developed new thin-film materials generating the...

Read More
Nov
24
2022

AcouSort presents at Stora Aktiedagen in Stockholm, November 30, addressing current developments in the vibrant cell therapy space

On November 30, 2022, CEO Torsten Freltoft will present at Stora Aktiedagen in Stockholm. In his presentation, Torsten will...

Read More